HHC ACO Inc., an Accountable Care Organization | NYC Health + Hospitals

COVID-19 ALERT: Find Community Testing Sites. Read the Travel Advisory. Learn more about NYC Test & Trace Corps. Check Testing Wait Times. COVID-19 Vaccine Info.

ACO Name and Location

HHC ACO Inc
Previous Names: N/A
50 Water Street, 7th Floor
New York, NY 10004

ACO Primary Contact

Matthew Siegler
212-788-3479
SieglerM@nychhc.org

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture
Community Healthcare Network, Inc. Y
Coney Island Medical Practice Plan, P.C. Y
Downtown Bronx Medical Associates, P.C. Y
Harlem Medical Associates, P.C. Y
Icahn School of Medicine at Mount Sinai (DBA: Mount Sinai Elmhurst Faculty Practice Group) Y
Metropolitan Medical Practice Plan, P.C. Y
New York City Health and Hospitals Corporation Y
University Physicians of Brooklyn, Inc Y

ACO governing body:

Member
Last Name First Name Title/Position
Member’s Voting Power – Expressed as a percentage or number Membership Type ACO Participant Legal Business Name/DBA, if Applicable
Katz Mitchell Chair
1 ACO Participant Representative New York City Health and Hospitals Corporation
Siegler Matthew CEO
1 ACO Participant Representative New York City Health and Hospitals Corporation
Kalkut Gary Vice President
1 ACO Participant Representative New York City Health and Hospitals Corporation
Ulberg, Jr. John E. Treasurer
1 ACO Participant Representative New York City Health and Hospitals Corporation
Rocha, Jr. Israel Secretary
1 ACO Participant Representative New York City Health and Hospitals Corporation
Peart Hyacinth Voting Member
1 Medicare Beneficiary Representative  
Cohen Andrea Voting Member
1 ACO Participant Representative New York City Health and Hospitals Corporation
Donnell Lori Voting Member
1 ACO Participant Representative University Physicians of Brooklyn, Inc.
Marcos Luis Voting Member
1 Other  
Moshirpur Jasmin Voting Member
1 ACO Participant Representative Mount Sinai Elmhurst Faculty Practice Group
Seigel Warren Voting Member
1 ACO Participant Representative Coney Island Medical Practice Plan, P.C.

Key ACO clinical and administrative leadership:

ACO Executive: Matthew Siegler
Chief Medical Officer: David Stevens, MD
Compliance Officer: Catherine Patsos, Esq.
Quality Assurance/Improvement Officer: David Stevens, MD

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Governance Committee Mitchell Katz, MD, Board Chair
Clinical Leadership & Quality Assurance Committee David Stevens, MD, Medical Director
Audit Committee John Ulberg, MPH, Treasurer

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Third Agreement Period
  • Performance Year 2019A (July 1, 2019 – December 31, 2019), $3,080,377
  • Second Agreement Period
  • Performance Year 2019 (January 1, 2019 – June 30, 2019), $1,540,960
  • Performance Year 2018, $2,967,275
  • Performance Year 2017, $2,182,360
  • Performance Year 2016, $1,586,859
  • First Agreement Period
  • Performance Year 2015, $6,052,364
  • Performance Year 2014, $2,644,605
  • Performance Year 2013, $3,639,766

Shared Savings Distribution

  • Third Agreement Period
  • Performance Year 2019A (July 1, 2019 – December 31, 2019)
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 37%
  • Proportion of distribution to ACO participants: 63%
  • Second Agreement Period
  • Performance Year 2019 (January 1, 2019 – June 30, 2019)
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 54%
  • Proportion of distribution to ACO participants: 46%
  • Performance Year 2018
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 48%
  • Proportion of distribution to ACO participants: 52%
  • Performance Year 2017
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 57%
  • Proportion of distribution to ACO participants: 43%
  • Performance Year 2016
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 85%
  • Proportion of distribution to ACO participants: 15%
  • First Agreement Period
  • Performance Year 2015
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 20%
  • Proportion of distribution to ACO participants: 80%
  • Performance Year 2014
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 28%
  • Proportion of distribution to ACO participants: 72%
  • Performance Year 2013
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 36%
  • Proportion of distribution to ACO participants: 64%

Quality Performance Results

2019 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 75.37 85.86
ACO-2 CAHPS: How Well Your Providers Communicate 89.63 94.11
ACO-3 CAHPS: Patients’ Rating of Provider 89.95 92.69
ACO-4 CAHPS: Access to Specialists 78.87 81.54
ACO-5 CAHPS: Health Promotion and Education 64.74 60.44
ACO-6 CAHPS: Shared Decision Making 59.62 62.78
ACO-7 CAHPS: Health Status/Functional Status 71.14 73.79
ACO-34 CAHPS: Stewardship of Patient Resources 17.69 26.17
ACO-45 CAHPS: Courteous and Helpful Office Staff 81.51 92.84
ACO-46 CAHPS: Care Coordination 81.45 86.89
ACO-8 Risk Standardized, All Condition Readmission 14.58 14.86
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 77.61 58.15
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91) 1.65 1.87
ACO-13 Falls: Screening for Future Fall Risk 77.73 84.04
ACO-14 Preventive Care and Screening: Influenza Immunization 73.41 74.77
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 92.59 78.04
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 88.26 70.40
ACO-19 Colorectal Cancer Screening 72.81 70.76
ACO-20 Breast Cancer Screening 76.21 73.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 89.29 82.17
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 18.98 13.88
ACO-40 Depression Remission at Twelve Months 17.54 13.58
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 74.32 75.04

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

  • Waiver for Payment for Telehealth Services:
  • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR §425.612(f) and 42 CFR §425.613.

WE ALWAYS PUT PATIENTS FIRST